[{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":null,"AttendeeRatingAvg":null,"AttendeeRatingCount":null,"AuthorBlock":"<presenter><u><i>BELLAL Moghis<\/i><\/u><\/presenter>. CA","CSlideId":"","ControlKey":"bff7ea09-76e8-4851-9673-5589200c167e","ControlNumber":"11937","DisclosureBlock":"","End":"4\/7\/2024 4:30:00 PM","HasWebcast":null,"Highlights":[],"Id":"11364","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":"cslide-player-enabled is not true","PositionInSession":"1","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"BELLAL MOGHIS","PresenterKey":"78b5b682-1bbe-4072-ac9e-e59f6c1cfd59","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Speaker","SearchResultFooter":"","SearchResultHeader":"Apr  7 2024  3:30PM","SessionId":"653","SessionOnDemand":"False","SessionTitle":"Novel technologies for precision medicine: Agilent Avida targeted sequencing and Claudin 18.2 IHC assay for Transcenta Therapeutics’ Osemitamab program","ShowChatLink":"false","Start":"4\/7\/2024 3:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Speaker","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":null,"AttendeeRatingAvg":null,"AttendeeRatingCount":null,"AuthorBlock":"<presenter><u><i>CAROLINE Germa<\/i><\/u><\/presenter>. CA","CSlideId":"","ControlKey":"3c1b8988-8fe8-434b-a082-dadf08cffd93","ControlNumber":"11938","DisclosureBlock":"","End":"4\/7\/2024 4:30:00 PM","HasWebcast":null,"Highlights":[],"Id":"11365","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":"cslide-player-enabled is not true","PositionInSession":"2","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"CAROLINE GERMA","PresenterKey":"98729754-65d0-4840-8809-01ca50000b4f","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Speaker","SearchResultFooter":"","SearchResultHeader":"Apr  7 2024  3:30PM","SessionId":"653","SessionOnDemand":"False","SessionTitle":"Novel technologies for precision medicine: Agilent Avida targeted sequencing and Claudin 18.2 IHC assay for Transcenta Therapeutics’ Osemitamab program","ShowChatLink":"false","Start":"4\/7\/2024 3:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Speaker","Topics":null,"cSlideId":""}]